Related Experiment Video

Updated: Jun 9, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Comment on 'Integrative genomic profiling of human prostate cancer'

L Bullinger, J Krönke, V Gaidzik

    Leukemia
    |September 3, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
    09:43

    Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

    Published on: August 1, 2025

    Related Experiment Videos

    Last Updated: Jun 9, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
    09:43

    Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

    Published on: August 1, 2025

    Related Concept Videos

    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...

    Articles linked to this work by shared authors, journal, and citation graph.

    Characteristics of patients with epithelioid hemangioendothelioma (EHE): a retrospective analysis of the Charité- Universitätsmedizin Berlin.

    Journal of cancer research and clinical oncology·2026

    The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.

    Leukemia·2026

    Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

    Blood cancer journal·2025

    Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative.

    ESMO open·2025

    Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population.

    Leukemia research·2024

    Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report.

    Infection·2024

    Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

    Leukemia·2026

    Cheminformatic identification of small molecules targeting acute myeloid leukemia.

    Leukemia·2026

    Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

    Leukemia·2026

    Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

    Leukemia·2026

    PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

    Leukemia·2026

    TP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapy.

    Leukemia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us